1st Quarter - Amendment
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
Firm
Client
Income
$80,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2019 | $60,000 | Replaced |
| 1st Quarter - Amendment (this page) | Oct 17, 2019 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety issues; Prescription drug abuse; Issues related to opioids policies and offsets; H.R. 965/ S. 340, CREATES Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.